GlassScriptPhysician profile
Kevin S Davis
NPI 1629069141
$923.29
in general payments reported to CMS, 2019-2025
13 companies · $28.60 in 2025
The $28.60 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $88.56 · 2021: $166 · 2022: $83.73 · 2023: $281 · 2024: $162 · 2025: $28.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.32 |
| Education | $110.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $235.51 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $216.47 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Daiichi Sankyo INC. | $133.33 | 2020-2023 | Injectafer |
| Biogen, INC. | $73.89 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $72.70 | 2023 | Myfembree |
| Myovant Sciences INC. | $32.04 | 2021 | |
| Pfizer INC. | $30.46 | 2024 | |
| Intuitive Surgical, INC. | $29.03 | 2020 | |
| Coopersurgical, INC. | $27.20 | 2019 | |
| Therapeuticsmd, INC. | $23.99 | 2020 | |
| Organon LLC | $18.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.16 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.